Costs tied to No Surprises Act's IDR process hit $22B in 2025, study finds
Costs associated with the No Surprises Act's dispute resolution process reached $22.4 billion at the end of 2025, according to a new analysis.
Search fresh public links, source activity, and ready-to-use post angles for Costs/Reimbursement.
Fresh curated links around Costs/Reimbursement are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Costs associated with the No Surprises Act's dispute resolution process reached $22.4 billion at the end of 2025, according to a new analysis.
At the end of the day, the most important question is a simple one: Do you actually know if you’re being reimbursed correctly? The post What Healthcare Organizations Miss When It C...
Summary: Medicare has steadily expanded the services that Federally Qualified Health Centers can bill outside the Prospective Payment System, creating new reimbursement opportunit...
On June 23, 2026, the U.S. Department of Justice (DOJ) announced that it charged 11 defendants in connection with over two billion dollars in fraudulent claims for amniotic wound a...
Medicare’s reimbursement of remote patient monitoring services, beginning in 2019, offered a meaningful patient care opportunity, paying to give patients devices to measure their h...
CMS announced that the pilot test of bundling musculoskeletal reimbursement is going nationwide.
Women’s health startups should plan for reimbursement early, as limited research and evidence can make securing coverage difficult, a new report explains. The post The Reimbursemen...
Four mandatory value-based payment programs were associated with more than $3 billion in aggregated administrative costs compared to non-participating hospitals, researchers' analy...
HHS is reviving a rebate program for 340B drug discounts after the previous pilot was blocked in court earlier this year. Providers say the change will burden already cash-strapped...
The Skyclarys campaign has exposed a drug reimbursement system designed for bureaucrats and pharmaceutical companies, not the patients whose lives depend on its decisions.
Disproportionate share hospitals are expected to see a 5.8% net reduction in OPPS revenue under the proposal, while for-profits are expecting a 7.4% net increase, KFF highlighted i...
The arbitration system stopped many surprise bills, but provider payouts soared to $16.6 billion in 2025, potentially shifting costs to policyholders
Hospitals and other medical providers are increasingly asking for payment before providing care, collecting more of what patients might owe as rising insurance deductibles add to A...
Healthcare in the United States is in a death spiral. Costs continue to rise, chronic diseases consume 90% of healthcare spending, and millions of Americans feel trapped in a syste...
Your plan says 70 percent reimbursement, and the check says otherwise. That check is correct, and it's based on a number that actually determines what you get back.
The true cost of “vertical integration”: patients directed to a higher-priced location for procedures. Or forced to buy from their insurer’s wholly owned pharmacy, which may not st...
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is that not only is this terrible for patien...
By Bryce Platt, PharmD Kids are heading back to school, but the drug channel never stops handing out homework. Fortunately, we did some of the research prep for you. In this...
Medical service costs in California workers’ compensation rose 5% last year on the back of growth in both average payments and utilization, a new report shows. The Workers’ Compens...
The price of saving a newborn’s life can extend far beyond the hospital walls. A new analysis published in the Journal of Perinatology is drawing attention to a largely invisible c...
The Trump administration advances a claims-based rebate model for select 340B drugs as a new bipartisan Senate bill would block it, forcing health systems to track three reform pat...
A verbal yes, a six-figure bill, then a payout that barely moved the needle
VBC aligns reimbursements to outcomes, emphasizing the quality and effectiveness, not quantity, of healthcare activities. But the same cost constraints driving interest in VBC can...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.